ACLY and autoimmune polyendocrinopathy: A post-treatment or early-pregnancy decline in aCL IgG, aPS/PT IgM, or aβ2GPI IgM is associated with successful pregnancy in APS-RPL patients, whereas early-pregnancy elevations in aPS/PT IgM and IgG are strongly linked to pregnancy loss.